Health Trials

Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Treatment of Radiation and Cisplatin Induced Toxicities with Tempol

A 10 week trial to assess the ability of Tempol to prevent and/or reduce toxicities associated with cisplatin and radiation treatment in head and neck cancer patients. Over the course of the 10 week trial, mucositis, nephrotoxicity, and ototoxicity will be monitored and assessed.

Participants needed: 120
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Matrix Biomed, Inc.Updated: Nov 20, 2024Locations: 9
Eligibility criteria

Be ≥18 years of age with medically diagnosed squamous cell cancer of the head an... [+7]

Prior radiotherapy of the head and neck; [+15]

Read more
Status: Available

Treatment of Metastatic Cancer in Terminally Diagnosed Patients

The objective is to provide terminally diagnosed patients with a last line of treatment while improving overall quality of life. Tempol can be added to any chemotherapy regimen to potentially reduce side effects and overcome chemoresistance.

Trial details
Biological sex: AllType: Expanded AccessSponsor: Matrix Biomed, Inc.Updated: Sep 1, 2022Locations: 1
Eligibility criteria

metastatic terminally diagnosed cancer

Read more
Status: Available

A Single Patient Compassionate Use of MBM-02 (Tempol) for the Treatment of Prostate Cancer

A single patient compassionate use clinical trial for the use of MBM-02 (TEMPOL) for the treatment of prostate cancer. The single patient will be exposed to orally administered TEMPOL for up to 12 months at a maximum total daily dose of 800mg.

Trial details
Age: 18+Biological sex: MaleType: Expanded AccessSponsor: Matrix Biomed, Inc.Updated: May 5, 2021Locations: 1
Eligibility criteria

Biochemical Recurrent Prostate Cancer

Read more